Myeloid HIF-1 is protective in Helicobacter pylori-mediated gastritis

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3259-3266

  Matak, Pavle ^a,b,c   Heinis, Mylène ^a,b,c   Mathieu, Jacques R R ^a,b,c   Corriden, Ross ^d   Cuvellier, Sylvain ^a,b,c   Delga, Stéphanie ^a,b,c   Mounier, Rémi ^a,b,c,e   Rouquette, Alexandre ^f   Raymond, Josette ^f   Lamarque, Dominique ^g   Emile, Jean Franҫois ^g   Nizet, Victor ^d   Touati, Eliette ^h   Peyssonnaux, Carole ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITÉ LYON 1   (France)

^f Hôpital Cochin ^*  (France)

^g LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^h INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; UNCLASSIFIED DRUG; AUTACOID; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CYTOKINE; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STOMACH BIOPSY; WILD TYPE; ANIMAL; BIOPSY; BONE MARROW CELL; COMPLICATION; DISEASE MODEL; GASTRITIS; GENETICS; HELICOBACTER PYLORI; IMMUNOLOGY; MACROPHAGE; METABOLISM; MICROBIOLOGY; NEUTROPHIL; PATHOLOGY; STOMACH MUCOSA; TRANSGENIC MOUSE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOPSY; CYTOKINES; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MICE, TRANSGENIC; MYELOID CELLS; NEUTROPHILS;

EID: 84925849366     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401260     Document Type: Article

References (44)

1. Fox, J. G., and T. C. Wang. 2007. Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 117: 60-69.
2. Kaparakis, M., A. K. Walduck, J. D. Price, J. S. Pedersen, N. van Rooijen, M. J. Pearse, O. L. Wijburg, and R. A. Strugnell. 2008. Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect. Immun. 76: 2235-2239.
3. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11: 750-761.
4. Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787-795.
5. Quiding-Järbrink, M., S. Raghavan, and M. Sundquist. 2010. Enhanced M1 macrophage polarization in human Helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS One 5: e15018.
6. Hu, C. J., L. Y. Wang, L. A. Chodosh, B. Keith, and M. C. Simon. 2003. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 23: 9361-9374.
7. Takeda, N., E. L. O'Dea, A. Doedens, J. W. Kim, A. Weidemann, C. Stockmann, M. Asagiri, M. C. Simon, A. Hoffmann, and R. S. Johnson. 2010. Differential activation and antagonistic function of HIF-alpha isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24: 491-501.
8. Semenza, G. L. 2012. Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408.
9. Nizet, V., and R. S. Johnson. 2009. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9: 609-617.
10. Dehne, N., and B. Brüne. 2009. HIF-1 in the inflammatory microenvironment. Exp. Cell Res. 315: 1791-1797.
11. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Förster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
12. Cane, G., A. Ginouvès, S. Marchetti, R. Buscà, J. Pouysségur, E. Berra, P. Hofman, and V. Vouret-Craviari. 2010. HIF-1alpha mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour. Cell. Microbiol. 12: 640-653.
13. Mahabeleshwar, G. H., M. A. Qureshi, Y. Takami, N. Sharma, J. B. Lingrel, and M. K. Jain. 2012. A myeloid hypoxia-inducible factor 1α-Krüppel-like factor 2 pathway regulates Gram-positive endotoxin-mediated sepsis. J. Biol. Chem. 287: 1448-1457.
14. Peyssonnaux, C., V. Datta, T. Cramer, A. Doedens, E. A. Theodorakis, R. L. Gallo, N. Hurtado-Ziola, V. Nizet, and R. S. Johnson. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115: 1806-1815.
15. Walmsley, S. R., C. Print, N. Farahi, C. Peyssonnaux, R. S. Johnson, T. Cramer, A. Sobolewski, A. M. Condliffe, A. S. Cowburn, N. Johnson, and E. R. Chilvers. 2005. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med. 201: 105-115.
16. Thompson, A. A., P. M. Elks, H. M. Marriott, S. Eamsamarng, K. R. Higgins, A. Lewis, L. Williams, S. Parmar, G. Shaw, E. E. McGrath, et al. 2014. Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish. Blood 123: 366-376.
17. Fang, H. Y., R. Hughes, C. Murdoch, S. B. Coffelt, S. K. Biswas, A. L. Harris, R. S. Johnson, H. Z. Imityaz, M. C. Simon, E. Fredlund, et al. 2009. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114: 844-859.
18. Hirota, S. A., P. L. Beck, and J. A. MacDonald. 2009. Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease. Recent Pat. Inflamm. Allergy Drug Discov. 3: 1-16.
19. Kempf, V. A., M. Lebiedziejewski, K. Alitalo, J. H. Wälzlein, U. Ehehalt, J. Fiebig, S. Huber, B. Schütt, C. A. Sander, S. Müller, et al. 2005. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 111: 1054-1062.
20. Patel, N. J., O. Zaborina, L. Wu, Y. Wang, D. J. Wolfgeher, V. Valuckaite, M. J. Ciancio, J. E. Kohler, O. Shevchenko, S. P. Colgan, et al. 2007. Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G134-G142.
21. Rupp, J., J. Gieffers, M. Klinger, G. van Zandbergen, R. Wrase, M. Maass, W. Solbach, J. Deiwick, and T. Hellwig-Burgel. 2007. Chlamydia pneumoniae directly interferes with HIF-1alpha stabilization in human host cells. Cell. Microbiol. 9: 2181-2191.
22. Lee, A., J. O'Rourke, M. C. De Ungria, B. Robertson, G. Daskalopoulos, and M. F. Dixon. 1997. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112: 1386-1397.
23. Israel, D. A., N. Salama, C. N. Arnold, S. F. Moss, T. Ando, H. P. Wirth, K. T. Tham, M. Camorlinga, M. J. Blaser, S. Falkow, and R. M. Peek, Jr. 2001. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Invest. 107: 611-620.
24. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
25. Ryan, H. E., M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60: 4010-4015.
26. Ferrero, R. L., P. Avé, F. J. Radcliff, A. Labigne, and M. R. Huerre. 2000. Outbred mice with long-term Helicobacter felis infection develop both gastric lymphoid tissue and glandular hyperplastic lesions. J. Pathol. 191: 333-340.
27. Eaton, K. A., M. J. Radin, and S. Krakowka. 1993. Animal models of bacterial gastritis: the role of host, bacterial species and duration of infection on severity of gastritis. Zentralbl. Bakteriol. 280: 28-37.
28. Fenoglio-Preiser, C. 1999. The Non-Neoplastic Stomach. Gastrointestinal Pathology: An Atlas and Text, 2nd Ed. Lippincott-Raven, Philadelphia, p. 153-274.
29. Salama, N. R., M. L. Hartung, and A. Müller. 2013. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat. Rev. Microbiol. 11: 385-399.
30. Mannick, E. E., L. E. Bravo, G. Zarama, J. L. Realpe, X. J. Zhang, B. Ruiz, E. T. Fontham, R. Mera, M. J. Miller, and P. Correa. 1996. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56: 3238-3243.
31. Pignatelli, B., B. Bancel, J. Estève, C. Malaveille, S. Calmels, P. Correa, L. M. Patricot, M. Laval, N. Lyandrat, and H. Ohshima. 1998. Inducible nitric oxide synthase, anti-oxidant enzymes and Helicobacter pylori infection in gastritis and gastric precancerous lesions in humans. Eur. J. Cancer Prev. 7: 439-447.
32. Touati, E., V. Michel, J. M. Thiberge, N. Wuscher, M. Huerre, and A. Labigne. 2003. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 124: 1408-1419.
33. Crabtree, J. E., T. M. Shallcross, R. V. Heatley, and J. I. Wyatt. 1991. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32: 1473-1477.
34. Harris, P. R., L. E. Smythies, P. D. Smith, and A. Dubois. 2000. Inflammatory cytokine mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates. J. Infect. Dis. 181: 783-786.
35. Allen, L. A. 2007. Phagocytosis and persistence of Helicobacter pylori. Cell. Microbiol. 9: 817-828.
36. Cahill, R. J., C. Kilgallen, S. Beattie, H. Hamilton, and C. O'Morain. 1996. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 38: 177-181.
37. Lynch, D. A., N. P. Mapstone, A. M. Clarke, G. M. Sobala, P. Jackson, L. Morrison, M. F. Dixon, P. Quirke, and A. T. Axon. 1995. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 36: 346-350.
38. Giatromanolaki, A., E. Sivridis, E. Maltezos, N. Athanassou, D. Papazoglou, K. C. Gatter, A. L. Harris, and M. I. Koukourakis. 2003. Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther. 5: R193-R201.
39. Lee, K. S., S. R. Kim, S. J. Park, H. S. Park, K. H. Min, S. M. Jin, M. K. Lee, U. H. Kim, and Y. C. Lee. 2006. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J. Allergy Clin. Immunol. 118: 120-127.
40. Rosenberger, C., C. Solovan, A. D. Rosenberger, L. Jinping, R. Treudler, U. Frei, K. U. Eckardt, and L. F. Brown. 2007. Upregulation of hypoxia-inducible factors in normal and psoriatic skin. J. Invest. Dermatol. 127: 2445-2452.
41. Ferrero, R. L. 2005. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol. Immunol. 42: 879-885.
42. Bhattacharyya, A., R. Chattopadhyay, E. H. Hall, S. T. Mebrahtu, P. B. Ernst, and S. E. Crowe. 2010. Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G1177-G1186.
43. Odegaard, J. I., R. R. Ricardo-Gonzalez, M. H. Goforth, C. R. Morel, V. Subramanian, L. Mukundan, A. Red Eagle, D. Vats, F. Brombacher, A. W. Ferrante, and A. Chawla. 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447: 1116-1120.
44. Imtiyaz, H. Z., E. P. Williams, M. M. Hickey, S. A. Patel, A. C. Durham, L. J. Yuan, R. Hammond, P. A. Gimotty, B. Keith, and M. C. Simon. 2010. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest. 120: 2699-2714.